ARISAPH
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jan 2018)
What this means for you
This application is over — abandoned 08 Jan 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86278628
- Mark type
- Stylized text
- Filed
- 12 May 2014
- Published for opposition
- 07 Oct 2014
- Abandoned
- 08 Jan 2018
- Attorney of record
- Joshua Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmacological preparations and substances for the treatment of diabetes, cancer, and atherosclerosis
Owner
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
Prior registrations
Prosecution history
- 08 Jan 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 08 Jan 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 06 May 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 May 2017 — SOU EXTENSION 5 GRANTED
- 01 May 2017 — SOU EXTENSION 5 FILED
- 01 May 2017 — SOU TEAS EXTENSION RECEIVED
- 15 Dec 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2016 — SOU EXTENSION 4 GRANTED
- 18 Nov 2016 — SOU EXTENSION 4 FILED
- 14 Dec 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Nov 2016 — SOU TEAS EXTENSION RECEIVED
- 03 May 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2016 — SOU EXTENSION 3 GRANTED
- 25 Apr 2016 — SOU EXTENSION 3 FILED
- 25 Apr 2016 — SOU TEAS EXTENSION RECEIVED